Literature DB >> 201569

Interferon induction by vesicular stomatitis virus and its role in virus replication.

J Vilcek, S Yamazaki, E A Havell.   

Abstract

Antibody against human fibroblast interferon increased the yields of vesicular stomatitis virus in human cells. The results show that endogenous interferon produced in the course of multicycle vesicular stomatitis virus infection depresses virus yields.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201569      PMCID: PMC421314          DOI: 10.1128/iai.18.3.863-865.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Suppression of human interferon production by inhibitors of glycosylation.

Authors:  E A Havell; J Vilcek; E Falcoff; B Berman
Journal:  Virology       Date:  1975-02       Impact factor: 3.616

2.  Defective interfering particles with covalently linked [+/-]RNA induce interferon.

Authors:  P I Marcus; M J Sekellick
Journal:  Nature       Date:  1977-04-28       Impact factor: 49.962

3.  Enhancing effect of interferon antiserum on viral growth.

Authors:  B Fauconnier
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

4.  Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus.

Authors:  R R Wagner; A S Huang
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

5.  Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction.

Authors:  M W Davey; E Sulkowski; W A Carter
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

6.  Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.

Authors:  Y H Tan; E L Schneider; J Tischfield; C J Epstein; F H Ruddle
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

7.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

8.  Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.

Authors:  J Vilcek; E A Havell
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

9.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

  10 in total
  6 in total

1.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 2.  Mechanisms of persistent infections by cytopathic viruses in tissue culture. Brief review.

Authors:  R M Friedman; J M Ramseur
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  Stimulation of human gamma interferon production by diterpene esters.

Authors:  Y K Yip; R H Pang; J D Oppenheim; M S Nachbar; D Henriksen; I Zerebeckyj-Eckhardt; J Vilcek
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.

Authors:  J Vilcek; I T Sulea; I L Zerebeckyj; Y K Yip
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

6.  Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells.

Authors:  E A Havell
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.